Israël Fortin

EMPLOIS

Radio-oncologue (Cancers gynécologiques, cancer du sein, cancers neurologiques, cancers hématologiques, stéréotaxie et traitements palliatifs) Hôpital Maisonneuve-Rosemont, Montréal, 2018 - à ce jour

Radio-oncologue (Cancers gynécologiques, cancer du sein, stéréotaxie et traitements palliatifs) Centre Hospitalier de l’Université de Montréal, Montréal, 2015-2018

FORMATION

Maitrise QUEOPS-i (Qualité, Évaluation, Organisation, Performance, Sécurité) École de Santé Publique de l’Université de Montréal, 2016-2018

Felllowship en radiothérapie intra-opératoire Hôpital Gregorio Marañon, Madrid, Espagne, 2015

Fellowship en gynécologie – spécialisation en curiethérapie intracavitaire et interstitielle guidée par IRM et TRUS – curiethérapie du sein Medical University of Vienna, Vienne, Autriche, 2014-2015

Examen du Collège Royal des médecins et chirurgiens du Canada Montréal et Ottawa, 2014

Résidence en Radio-oncologie, mention au tableau d’honneur du doyen Université de Montréal, Montréal, 2009 - 2014

Examen du Conseil médical du Canada (LCMC) partie I et II Université de Montréal, Montréal, 2009 - 2010

Doctorat en médecine, mention au tableau d’honneur du doyen Université de Montréal, Montréal, 2005 -2009

Maitrise en biologie cellulaire et moléculaire du cancer Centre de recherche en cancérologie de l’Hôtel-Dieu de Québec, Université Laval, Québec, 2003 - 2005

Baccalauréat en microbiologie – Profil international Université Laval, Québec et Université Paul Sabatier, Toulouse, 2000 - 2003

• 08-01-2018 Insuffler plus d’humanité dans l’annonce du diagnostic
• 25-11-2017 Viens voir le beau cancer...
• 09-10-2019 Les hommes aussi peuvent être atteints du cancer du sein
• 24-04-2019 Quebec doctor performs innovative breast cancer treatment
• 10-10-2018 Cancer: Marie Eykel veut sensibiliser les Québécoises
• 01-09-2017 Initiative innovante Les patients accompagnateurs partenaires de l’équipe de soin au Québec
• 21-05-2019 Israël Fortin: carburer à la curiosité
• 05-04-2019 Une nouvelle procédure à l'Hôpital Maisonneuve-Rosemont permet d'administrer la radiothérapie beaucoup plus rapid
• 22-03-2021 Vivre avec un diagnostic de maladie grave

Taggar A., Martell K., Leung E., Banerjee R.,  Doll C.M., Fortin I., Changing Landscape of Radical Radiotherapy Practices with a Focus on Interstitial Brachytherapy for Cervical Cancer: A Pan-Canadian Survey of Radiation Oncologists,  PRO,  october 2021

Pötter R. , Tanderup K., Schmid M.P., Jürgenliemk-Schulz I., Haie-Meder C., Fokdal L.U., Sturdza A.E., Hoskin P., Mahantshetty U., Segedin B., Bruheim K., Fleur Huang , Bhavana Rai , Rachel Cooper , Elzbieta van der Steen-Banasik , van Limbergen E, Rumwell Pieters B., Tan L., Nout R, De Leeuw A., Ristl R., Petric P, Nesvacil N, Kirchheiner K, Kirisits C, … Fortin I., …, Lindegaard J, MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study, The Lancet Oncology, 2021

Pomey M., De Guise M., Desforges M., Bouchard K., Vialaron C., Normandin L., Iliescu-Nelea M., Fortin I., Ganache I., Régis C, Rosberger Z., Charpentier D., Bélanger L., Dorval M., Ghadiri D. P., Lavoie-Tremblay M., Boivin A., Pelletier JF., Fernandez N.,  and Danino A.M. The patient advisor, an organizational resource as a lever for an enhanced oncology patient experience (PAROLEonco): a longitudinal multiple case study protocol, BMC Health Services Research, 2021 

Wong P., Lambert L., Thanomsack P., Coulombe G., Lambert C., Charpentier A., Barkati M., Fortin I., Lafontaine J., Roberge D., Quality of life: A prospective Randomized Trail of Palliative Volumetric Arc Therapy versus 3D-Conventional Radiation Therapy, IJROBP, Décembre 2020

Leung E, D'Souza D, Bachand F, Han K, Alfieri J, Huang F, Vigneault E, Barkati M, Wiebe EM, Foster W, Fortin I, Velker V, Bowes D, Barnes E, Patil N, Banerjee R, Barbera L, Ravi A.,  MRI-based interstitial brachytherapy for vaginal tumors: A multi-institutional study on practice patterns, contouring, and consensus definitions of target volumes., Brachytherapy, 2019

Mahantshetty U, Sturdza A, Naga Ch P, Berger D, Fortin I, Motisi L, Schmid MP, Aravindakshan D, Ghadi Y, Swamidas JV, Chopra S, Gurram L, Nesvacil N, Kirisits C, Pötter R., Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcome. Radiother Oncol. 2019

Nomden CN, Pötter R, de Leeuw AAC, Tanderup K, Lindegaard JC, Schmid MP, Fortin I, Haie-Meder C, Mahantshetty U, Hoskin P, Segedin B, Bruheim K, Rai B, Huang F, Cooper R, Van Der Steen Banasik E, Van Limbergen E, Jürgenliemk-Schulz IM; EMBRACE Collaborative Group. Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort, Radiother Oncol, 2019

Pötter R., Tanderup K., Kirisits C., de Leeuw A., Kirchheiner K., Nout R., Tee Tan L., Haie-Meder C., Mahantshetty U., Segedin B., Hoskin P., Bruheim P., Rai B., Huang F., van Limbergen E., Schmid M., Nesvacil N., Sturdza A., Fokdal L., Boje Kibsgaard N., Georg D., Assenholt M., Seppenwoolde Y., Nomden C., Fortin I., Chopra S., van der Heide U., Rumpold T., Lindegaard J., Jürgenliemk-Schulz I., The EMBRACE collaborative group, The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies, Clinical and Translational Radiation Oncology, 2018

Mathieu D., Shahvary N., Côté N., Boulva K., Meloche-Dumas L., Vu T., Patocskai E., Bernier C., Roberge D., Fortin I., Helical Tomotherapy for Postmastectomy Radiotherapy after Immediate Left Breast Reconstruction: A Case Study. Cureus. 2017 Jul 12;9(7):

Barkati. M., King Bronwyn., Fortin I., Portelance L., Viswanathan A., Fyles A., Beriwal S., Alfieri J., Lim K., Harkendride M., Small W., (…) Gaffney D., IMRT for Vulvar Carcinoma: Changes in Practice Over 5 Years, Radiotherapy and Oncology., September 2016 

Fortin I., Tanderup K., Mahantshetty U., Haie-Meder C., Lindegaard JC.,  Segedin B., Petric P., Jürgenliemk-Schulz IM., Hoskin P., Kirisits C., Pötter R., Image Guided Brachytherapy in cervical cancer: a comparison between intracavitary and combined intracavitary/interstitial brachytherapy in regard to doses to HR CTV, OARs and late morbidity – early results from the EMBRACE study in 999 patients, Brachytherapy 2016. 

Fortin I., Jürgenliemk-Schulz IM, Mahantshetty U, Haie-Meder C, Hoskin P, Segedin B, Kirisits C, Tanderup K, Lindegaard JC, Kirchheiner K, Pötter R, Distant Metastases in Locally Advanced Cervical Cancer, Pattern of Relapse and Prognostic Factors: Early Results From the EMBRACE Study, IJROBP 2015

Fortin I., Carrier, J., Beauchemin, M., Beliveau-Nadeau, D., Delouya, G., Taussky. D., Fiducial Markers In The Prostate Bed For Post Prostatectomy External Beam Radiation Therapy: Improved Accuracy As Compared To The Use Of Surgical Clip, Strahlentherapie und onkologie, 190(5):467-71, Mai 2014

Fortin I., Fortin B., Clavel S., Lambert L., Alizadeh M., Filion E., Guertin L., Nguyen-Tan F. P., Xerostomia in patients treated for an oropharyngeal carcinoma: comparing LINAC-based Intensity-modulated radiation therapy to helical tomotherapy, Head and Neck, aout 2013 

Alizadeh M.,  Lambert L.,  Filion E.,  Guertin L., Fortin I., Soullières D., Bélair M., Nguyen-Tan F. P., Adaptive Radiation Therapy in HPV Positive Oropharyngeal Carcinoma: A Preliminary Toxicity Report, Radiotherapy and oncology,  Volume 106, Supplement 1, Page S54

Barkati M., Fortin I., Mileshkin, L., Bernshaw D., Carrier J-F., Narayan K., Hemoglobin Level in Cervix Cancer: a Surrogate for an Infiltrative Phenotype, International Journal of Gynecological Cancer, mai 2013, 23(4):724-9

Trepanier P., Fortin I., Lambert C., Lacroix F., A Monte Carlo based formalism to identify potential locations at high risk of tumor recurrence with a numerical model for glioblastoma multiforme. Med. Phys. 39, 6682, 2012

Trepanier P., Fortin I., Lambert C., et Lacroix F., Toward predicting the location of GBM recurrence after radiotherapy using patient‐specic DTI and numerical modelling, Medical Physics, Volume 38, Issue 6, p.3743, 2011

Selleck W., Fortin I., Sermwittayawong D., Côté J., Tan S., The Saccharomyces cerevisiae piccolo NuA4 histone acetyltransferase complex requires the enhancer of polycomb A domain and chromodomain to acetylate nucleosomes, Molecular and cellular biology, Vol. 25, No. 13,  Juillet 2005 

Brisson L., Bolduc N., Ouellet M., Pître F., Fortin I., Cytological features of programmed cell death in Nicotiana tabacum cells in relation to the expression and localization of death regulators. Microscopy and Microanalysis Vol. 8, Supplement 2 : 248-250, 2002